Federal Discretionary Grants for Substance Use Disorders
CSFA Number: 444-26-2486
Agency Name
Department Of Human Services (444)
Agency Identification
IDHS SUPR
Agency Contact
Samantha Alonis
(773) 485-7192
samantha.alonis@illinois.gov
Short Description
Expand the availability of effective substance use disorder treatment, prevention and recovery services available to improve the lives of those affected by alcohol and substance use disorders, and to reduce the impact of alcohol and substance use disorders on individuals, families, communities and societies.
Federal Authorization
21st Century Cures Act. , Section 1003, Public Law 114-TBD.
Illinois Statue Authorization
N/A
Illinois Administrative Rules Authorization
N/A
Objective
Addressing the opioid abuse crisis within such States, used for carrying out activities that supplement activities pertaining to opioids undertaken by the State agency responsible for administering the substance abuse prevention and treatment block grant under subpart II of part B of title XIX of the Public Health Service Act (42 U.S.C. 300x?21 et seq.).
Prime Recipient
Yes
UGA Program Terms
N/A
Eligible Applicants
Other;
Applicant Eligibility
Limited to sub-recipient named in the federal grant award.
Beneficiary Eligibility
N/A
Types of Assistance
Formula Grants
Subject / Service Area
Human Services
Credentials / Documentation
No Credentials or Documentation are required. 2 CFR 200, Subpart E - Cost Principles applies to this program.
Preapplication Coordination
Applicants must have been named in application submitted to SAMHSA
Application Procedures
Applicants must have been named in application submitted to SAMHSA
Criteria Selecting Proposals
N/A
Award Procedures
Applicants must have been named in application submitted to SAMHSA
Deadlines
Applications for the upcoming fiscal year must be received prior to May 1st.
Range of Approval or Disapproval Time
From 90 to 120 days.
Appeals
N/A
Renewals
N/A
Formula Matching Requirements
Statutory formula is not applicable to this assistance listing. Matching requirements are not applicable to this assistance listing. MOE requirements are not applicable to this assistance listing.
Uses and Restrictions
Uses: (A) Improving State prescription drug monitoring programs. (B) Implementing prevention activities, and evaluating such activities to identify effective strategies to prevent opioid abuse. (C) Training for health care practitioners, such as best practices for prescribing opioids, pain management, recognizing potential cases of substance abuse, referral of patients to treatment programs, and overdose prevention. (D) Supporting access to health care services, including those services provided by Federally certified opioid treatment programs or other appropriate health care providers to treat substance use disorders. (E) Other public health-related activities, as the State determines appropriate, related to addressing the opioid abuse crisis within the State. Limitations: (1) notwithstanding any transfer authority in any appropriations Act, shall not be used for any purpose other than the grant program in subsection (c); and (2) shall be subject to the same requirements as substance abuse prevention and treatment programs under titles V and XIX of the Public Health Service Act (42 U.S.C. 290aa et seq., 300w et seq.). 2 CFR 200
Reports
Periodic Financial Reports, Periodic Performance Reports, and Close out reports are required.
Audits
In accordance with the provisions of 2 CFR 200, Subpart F - Audit Requirements, non-Federal entities that expend financial assistance of $750,000 or more in Federal awards will have a single or a program-specific audit conducted for that year. Non-Federal entities that expend less than $750,000 a year in Federal awards are exempt from Federal audit requirements for that year, except as noted in 2 CFR 200.503.
Records
Grantee must keep complete records on the disposition of funds, and records related to the grant must be retained for 3 years.
Account Identification
0646.44426.4900.001200NE FY25 Funded Program: 0001.44426.4900.001000PY; 0013.44426.4900.000200NE; 0592.44426.4900.000100NE; 0646.44426.4900.000300NE
Obligations
Fiscal Year 2021: $4,433,542 Fiscal Year 2022: $5,855,034 Fiscal Year 2025: $29,050,711
Range and Average of Financial Assistance
Fiscal Year 2021: $100,000 - $1,400,000 Average: $554,193 Fiscal Year 2022: $200,000 - $1,842,043 Average: $836,433 Fiscal Year 2025: $88,125 - $2,499,960 Average: $461,122
Program Accomplishments
Fiscal Year 2021: 8 awards made.
Regulations, Guidelines, and Literature
CFR 200/45 CFR Part 75 Uniform Administrative Requirements, Cost Principles, and Audit Requirements for HHS awards; also the HHS Grants Policy Statement.
Regional or Local Assistance Location
None.
Headquarters Office
Division of Substance Use Prevention and Recovery 600 East Ash Street, Building 500, Third Floor Springfield, IL 62703
Program Website
https://www.cfda.gov/programs/93.788 http://www.dhs.state.il.us/page.aspx?item=101591
Example Projects
SA00-060-5025 SBIRT (Ends 6/30/2024); SA00-060-5033 SOR; SA00-060-5035 Digital Recovery Toolkit; SA00-060-5050 IL SOR II; SA00-060-5034 SOR FQHC; SA00-060-5036 SOR RSC; SV00-060-5040 Emergency COVID; SA00-060-5100 IL Families in Recovery; SA00-060-5030 MAT-SOR; SA00-060-5031 PPW-OUD; SA00-06--5038 SOR Recovery Home Expansion; SA00-060-5032 SOR Hospital Screening and Warm Handoff; SA00-60-5039 SOR Oxford House; IPDO Illinois Prevent Prescription/Opioid Drug Overdoses-Related Deaths; SPF RX Strategic Prevention Framework for Prescription Drugs
Published Date
11/9/2020
Funding By Fiscal Year
FY 2025 : $29,050,711
Federal Funding
Notice of Funding Opportunities
Agency IDAward RangeApplication Range
Agency IDGrantee NameStart DateEnd DateAmount
43CCC03494-43CCC03494Family Guidance Centers, Inc.07/01/202306/30/20242,676,375
43CCC03493-43CCC03493Chestnut Health Systems, Inc.07/01/202306/30/20242,363,955
43CCC03495-43CCC03495GATEWAY FOUNDATION INC07/01/202306/30/20242,341,253
43CCC03709-43CCC03709HEALTH MANAGEMENT ASSOCIATES, INC07/01/202306/30/20241,959,784
43CCZ03569-43CCZ03569Prevention First, Inc.07/01/202306/30/20241,827,757